Acadia Pharmaceuticals
ACAD
ACAD
196 hedge funds and large institutions have $2.74B invested in Acadia Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 34
51% less call options, than puts
Call options by funds: $28.3M | Put options by funds: $57.5M
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
196
Holding in Top 10
1
Calls
$28.3M
Puts
$57.5M
Top Buyers
| 1 | +$56M | |
| 2 | +$51.8M | |
| 3 | +$44.1M | |
| 4 |
HM
HealthCor Management
New York
|
+$31M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.2M |
Top Sellers
| 1 | -$55.8M | |
| 2 | -$33M | |
| 3 | -$24.1M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$17.9M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$16.2M |